45 results
8-K
EX-99.1
TFFP
Tff Pharmaceuticals Inc
29 Apr 24
Regulation FD Disclosure
6:06am
with moderate to severe chronic kidney disease
8 Baseline Characteristics and Demographics Disposition Time on TFF TAC (weeks) Years with kidney disease … in Part A 9 7 No 23 W F 52 Pt 6 Still in Part A 6 N/A No 0.75 W F 41 Pt 7 Still in Part A 5 2 No 1.25 NH M 56 Pt 8 CLAD: Chronic Lung Allograft
8-K
EX-99.2
TFFP
Tff Pharmaceuticals Inc
27 Mar 24
Regulation FD Disclosure
4:01pm
immune suppression leads to acute rejection or chronic rejection leading to chronic lung allograft dysfunction (CL AD) Too much immune suppression … leads to infections, chronic kidney disease, and post transplant lymphoproliferative disease ~40,000 new and existing patients worldwide 2 $2 billion
424B5
TFFP
Tff Pharmaceuticals Inc
22 Mar 24
Prospectus supplement for primary offering
8:00am
, chronic pulmonary aspergillosis, allergic bronchopulmonary aspergillosis, aspergillus tracheobronchitis, and aspergillus bronchoanastomotic infections
8-K
EX-99.2
TFFP
Tff Pharmaceuticals Inc
19 Dec 23
TFF Pharmaceuticals Announces Reverse Stock Split
6:07am
aspergillosis (IPA) ▪ Chronic pulmonary aspergillosis (CPA) ▪ Allergic bronchopulmonary aspergillosis (ABPA) ▪ Aspergillus tracheobronchitis ▪ Aspergillus …
EAP: expanded access program; CLAD: chronic lung allograft dysfunction Data is from pre - database lock; Data cut off date: 11/17/23 TFF VORI
8-K
EX-99.3
rut20qg b7hwbgosvr
19 Dec 23
TFF Pharmaceuticals Announces Reverse Stock Split
6:07am
8-K
EX-99.4
1j8a0j07bywbsb
15 Aug 23
TFF Pharmaceuticals Announces Proposed Public Offering of Common Stock
6:11am
8-K
EX-99.3
8rfqz fo1kblm1
15 Aug 23
TFF Pharmaceuticals Announces Proposed Public Offering of Common Stock
6:11am
8-K
EX-99.1
c7lvp of90ljmblywpf
11 May 23
TFF Pharmaceuticals Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:01pm
8-K
EX-99.1
56kvqe70 ifrusn
11 May 22
TFF Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update
4:01pm
8-K
EX-99.2
7v8ksnc750 8fjr
24 Mar 22
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
4:02pm